Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-05-16 09:45:53 |
Versijas komentārs | |
Teksts |
Investor Conference Webinar about Olainfarm’s recent developments
On May 15 AS „Olainfarm” organized its Investor Conference Online
Webinar for investors to inform about the company’s recent
developments.
During the webinar the member of the management board of AS
„Olainfarm” Salvis Lapiņš informed that Olainfarm’s invesment
program will reach around 26 million lats in fixed assets over the
next 5 years. Part of the sum will be co-funded by the European
Union funds and other sources. About 14 million lats are planned
for Final dosage forms, chemical production and will allow to
introduce some new products, while 7 million lats are planned to be
invested in increase of company’s energy and environmental
efficiency.
Also, Salvis Lapiņš informed that in nearest time the export to
Ukraine will be started again, which was temporary stopped due to
overshipment.
Answering the questions sent in by
the investors, Salvis Lapiņš confirmed that Olainfarm is planning
to acquire another 20% of SIA “Silvanols” shares in nearest weeks.
Once it is done Olainfarm in total will own almost 70% of Silvanols
shares, thus becoming a majority shareholder.
According to Salvis Lapiņš, currently Silvanols capacity is used
for about one third, so there are improvements
possible.
Also, according to Salvis Lapiņš one of the short term priorities
of Olainfarm and a market to focus on is Albania. Company forecasts
a significant increase of its sales to Albania. Olainfarm has also
succeeded in strengthening its presence in the Lithuanian market
and for future markets company is looking at Turkey, South East
Asia and other countries.
The recorded “Olainfarm” webinar is available online:
http://ej.uz/OLF2013ieraksts,
and the presentation,
demonstrated during the webinar, can be found in the previously
published AS “Olainfarm” announcement:
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=557283&messageId=687539.
Olainfarm thanks all participants, who joined the webinar, and
encourages everybody to follow company’s announcements to get
information on the next webinar!
A/s OlainFarm is one of the
biggest pharmaceutical companies in Latvia with 40 years of
experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 30 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia.
Information prepared
by: Salvis Lapins |
Pielikumi |
|